These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24565386)

  • 21. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs.
    Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL
    Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenon does not modify mivacurium induced neuromuscular block.
    Kunitz O; Baumert JH; Hecker K; Coburn M; Beeker T; Zühlsdorff A; Fassl J; Rossaint R
    Can J Anaesth; 2005 Nov; 52(9):940-3. PubMed ID: 16251559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mivacurium compared with succinylcholine in children with liver disease.
    Green DW; Fisher M; Sockalingham I
    Br J Anaesth; 1998 Sep; 81(3):463-5. PubMed ID: 9861140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of heart rate variability response in children undergoing elective endotracheal intubation with and without neuromuscular blockade: a randomized controlled trial.
    Janda M; Bajorat J; Kudlik C; Pohl B; Schubert A; Nöldge-Schomburg G; Hofmockel R
    Paediatr Anaesth; 2013 Dec; 23(12):1153-9. PubMed ID: 23910069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged mivacurium-induced neuromuscular block. Case report.
    Arcioni R; Sanfilippo M; Romano R; Lappa A; Mercieri M; Müller TM; Marcotullio D
    Minerva Anestesiol; 1999 Oct; 65(10):737-9; discussion 740. PubMed ID: 10598432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intubating conditions and blockade after mivacurium, rocuronium and their combination in young and elderly adults.
    Motamed C; Donati F
    Can J Anaesth; 2000 Mar; 47(3):225-31. PubMed ID: 10730732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical pharmacology of mivacurium].
    Diefenbach C; Mellinghoff H
    Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency.
    Goudsouzian NG; d'Hollander AA; Viby-Mogensen J
    Anesth Analg; 1993 Jul; 77(1):183-5. PubMed ID: 8317728
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacodynamics of mivacurium in the rabbit with carbon tetrachloride-induced liver disease.
    Cheong MA; Kim KS; Lee GS
    Eur J Anaesthesiol; 2007 Sep; 24(9):789-95. PubMed ID: 17462115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mivacurium block in patients with abnormal plasma cholinesterase.
    Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Nov; 39(8):1001-2. PubMed ID: 8607297
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanism of pancuronium potentiation of mivacurium block: use of the isolated-arm technique.
    Motamed C; Kirov K; Lieutaud T; Duvaldestin P
    Anesth Analg; 2000 Sep; 91(3):732-5. PubMed ID: 10960409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity.
    Ostergaard D; Jensen FS; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Nov; 39(8):1016-8. PubMed ID: 8607300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged mivacurium neuromuscular block in children.
    Lejus C; Blanloeil Y; Le Roux N; Soulard D; Mesguish M; Burnat P; Duvaldestin P; Pinaud M
    Paediatr Anaesth; 1998; 8(5):433-5. PubMed ID: 9742542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different F-wave recovery after neuromuscular blockade with pancuronium and mivacurium.
    Dueck MH; Paul M; Sagawe P; Oberthuer A; Wedekind C; Boerner U
    Anesth Analg; 2004 Nov; 99(5):1402-1407. PubMed ID: 15502038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma cholinesterase activity and mivacurium resistance: report of a family.
    Naguib M; Gomaa M; Samarkandi AH; Bevan DR; Akkielah AK; Watson C; Billecke S; La Du BN
    Anesth Analg; 1999 Dec; 89(6):1579-82. PubMed ID: 10589654
    [No Abstract]   [Full Text] [Related]  

  • 36. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism.
    McGehee DS; Krasowski MD; Fung DL; Wilson B; Gronert GA; Moss J
    Anesthesiology; 2000 Aug; 93(2):510-9. PubMed ID: 10910502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing Neuromuscular Blockade Measurement Between Upper Arm (TOF Cuff®) and Eyelid (TOF Scan®) Using Mivacurium during General Anesthesia.
    Radkowski P; Ruść J; Kęska M; Sztaba K
    Med Sci Monit; 2024 May; 30():e943630. PubMed ID: 38693676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolonged neuromuscular blockade with mivacurium in a newborn].
    Doucet O; Martin L; Laffon M; Jonville-Bera AP; Mercier C
    Ann Fr Anesth Reanim; 1998; 17(7):725-7. PubMed ID: 9750810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical importance of plasma cholinesterase for the anaesthetist.
    Pedersen NA; Jensen FS
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):120-4. PubMed ID: 7710221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Varin F
    Anesthesiology; 2005 Jun; 102(6):1124-32. PubMed ID: 15915024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.